Articles
Papers and Presentations
- San Bernardino Sun
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
An ophthalmic surgical products company, recently received $35 million in capital funding
- San Gabriel Valley Tribune
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- San Jose Mercury News
ElectroIQ - ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company, recently received
- San Luis Obispo Tribune
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
An ophthalmic surgical products company, recently received $35 million in capital funding
- San Mateo County Times
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- Search Bug
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company, recently received
- SignonSanDiego.com
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- SiliconValley.com
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
An ophthalmic surgical products company, recently received $35 million in capital funding
- The State
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- State Journal-Register
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company, recently received
- State-Journal.com
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
An ophthalmic surgical products company, recently received $35 million in capital funding
Pages:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
|
